LXRX — LEXICON PHARMACEUTICALS INC

Ownership history in Caption Management, LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in LEXICON PHARMACEUTICALS INC (LXRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q3)
Avg. % of fund
0.01%
First filed
2021 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 2,000,000 +1,945,667 +3581.0% 0.02% $2.7M $1.35
2021 Q2 INITIATED 54,333 — — 0.00% $250K $4.59
% of Fund (quarterly)    LXRX price (monthly, adj. close)

Other funds also holding LXRX

As of 2025 Q4 — sorted by position size

Artal Group S.A. 3Y 7Y 21.91% Siren, L.L.C. 1.34% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.1% Sessa Capital IM, L.P. 3Y 7Y 0.06% Hennion & Walsh Asset Management, Inc. 3Y 0.04% Monaco Asset Management SAM 3Y 0.02% Vermillion & White Wealth Management Group, LLC 0.02% Straight Path Wealth Management 3Y 0.02% TWO SIGMA SECURITIES, LLC 3Y 7Y 0.02% Quarry LP 3Y 0.02%
← Back to Caption Management, LLC Holdings